You Position: Home > Paper

Current opinions about using of medication intervention as neuroprotective therapy for degenerative ocular fundus diseases

( views:828, downloads:124 )
Author:
No author available
Journal Title:
Chinese Journal of Ophthalmology
Issue:
10
DOI:
10.3760/cma.j.issn.0412-4081.2012.10.021
Key Word:
神经保护药;视网膜变性;青光眼;黄斑变性;药物疗法;Neuroprotective agents;Retinal degeneration;Glaucoma;Macular degeneration;Drug therapy

Abstract: Recently,many studies indicated that certain medications can delay the apoptosis of retinal nerve cells at different points during the process of apoptosis and have neuroprotective effect on preventing degenerative ocular fundus diseases.N-methyl-D-aspartate receptor (NMDAR) antagonists,NMDAR-associated calcium channel blockers and acetylcholine receptor agonists have been shown to have neuroprotective effects for retinal damages by inhibiting NMDA-induced excitotoxicity.The inhibitors of nitric oxide synthase (NOS) can prevent the cell apoptosis and reduce the retinal cell loss by suppressing the activity of NOS as well-as the production of the nitric oxide.Antioxidants and some Chinese traditional medicine with antioxidant activities can also have protective effect on retinal damage caused by degenerative ocular fundus diseases through their functions in decreasing the peroxidation reaction and the production of the superoxide radicals in the cells.In addition,activation of neurotrophic factor receptors by their ligands plays a key role in neuroprotective and trophic effects for the retina.All of these studies not only provide the foundation,but also offer new theoretical supports for drug neuroprotective therapies in clinical practice.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn